Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>Achromobacter xylosoxidans</i> respiratory tract infections in cystic fibrosis patients

1 Sept 2008

Abstract excerpt

Achromobacter xylosoxidans is a ubiquitous Gram-negative non-fermenting rod, recently characterized as an emerging pathogen in cystic fibrosis (CF) patients. Its pathogenic potential and prevalent transmission routes are still unclear. This study investigated the PFGE genetic pattern and antimicrobial resistance profile of 42 A. xylosoxidans isolates obtained over 4 years from the respiratory tract of 22 CF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Cystic Fibrosis Research Advances
Share to Infections and bacterial resistance

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19024606
DOI: 10.1111/j.1600-0463.2008.00995.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>Achromobacter xylosoxidans</i> respiratory tract infections in cystic fibrosis patientsPMID 19024606Read ↗

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literatureSemantic proximity Read ↗

Pathogenesis of <i>Achromobacter xylosoxidans</i> respiratory infections: colonization and persistence of airway epithelia and differential gene expression in synthetic cystic fibrosis sputum mediumSemantic proximity Read ↗

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.Semantic proximity Read ↗

<i>Achromobacter xylosoxidans</i> isolates exhibit genome diversity, variable virulence, high levels of antibiotic resistance and potential intrahost evolutionSemantic proximity Read ↗

Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.Semantic proximity Read ↗

JMM Profile: Achromobacter xylosoxidans: the cloak-and-dagger opportunistSemantic proximity Read ↗

Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.Semantic proximity Read ↗

Pathogenesis of Achromobacter xylosoxidans respiratory infections: colonization, persistence, and transcriptome profiling in synthetic cystic fibrosis sputum mediumSemantic proximity Read ↗

Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.Semantic proximity Read ↗

Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.Semantic proximity Read ↗

Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.Semantic proximity Read ↗

Use of Random Amplified Polymorphic DNA PCR To Examine Epidemiology of <i>Stenotrophomonas maltophilia</i> and <i>Achromobacter</i> ( <i>Alcaligenes</i> ) <i>xylosoxidans</i> from Patients with Cystic FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.